Extracellular ATP metabolism on vascular endothelial cells: A pathway with pro-thrombotic and anti-thrombotic molecules

Vascular Pharmacology

Volumn 75, Issue , 2015, Pages 1-6

  Fuentes, Eduardo ^a,b   Palomo, Iván ^a,b  

^a UNIVERSIDAD DE TALCA   (Chile)

^b Centro de Estudios en Alimentos Procesados (CEAP)   (Chile)

Author keywords

Adenosine; ADP; ATP; Endothelium; Inosine; Platelet; Thrombosis

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; INOSINE; 5' NUCLEOTIDASE; APYRASE; CD39 ANTIGEN; LEUKOCYTE ANTIGEN;

BLOOD CLOTTING; CATABOLISM; CELL METABOLISM; CIRCULATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME RELEASE; HEMOSTASIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; THROMBOSIS; VASCULAR ENDOTHELIUM; ANIMAL; METABOLISM; PHYSIOLOGY; THROMBOCYTE;

5'-NUCLEOTIDASE; ADENOSINE; ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIGENS, CD; APYRASE; BLOOD PLATELETS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; PLATELET ACTIVATION; THROMBOSIS;

EID: 84983121946     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2015.05.002     Document Type: Review

References (124)

1. Aird W.C. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 2007, 100(2):158-173.
2. Heitzer T., Schlinzig T., Krohn K., Meinertz T., Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001, 104(22):2673-2678.
3. Atkinson B., Dwyer K., Enjyoji K., Robson S.C. Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: Potential as therapeutic targets. Blood Cells Mol Dis 2006, 36(2):217-222.
4. Deaglio S., Robson S.C. Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity. Adv Pharmacol 2011, 61:301-332.
5. Kaczmarek E., Koziak K., Sevigny J., Siegel J.B., Anrather J., Beaudoin A.R., et al. Identification and characterization of CD39/vascular ATP diphosphohydrolase. J Biol Chem 1996, 271(51):33116-33122.
6. Hyman M.C., Petrovic-Djergovic D., Visovatti S.H., Liao H., Yanamadala S., Bouis D., et al. Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39. J Clin Invest 2009, 119(5):1136-1149.
7. Zimmermann H. Biochemistry, localization and functional roles of ecto-nucleotidases in the nervous system. Prog Neurobiol 1996, 49(6):589-618.
8. Helenius M., Jalkanen S., Yegutkin G. Enzyme-coupled assays for simultaneous detection of nanomolar ATP, ADP, AMP, adenosine, inosine and pyrophosphate concentrations in extracellular fluids. Biochim Biophys Acta 2012, 1823(10):1967-1975.
9. Burnstock G. Purinergic nerves. Pharmacol Rev 1972, 24(3):509-581.
10. Ralevic V., Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 1998, 50(3):413-492.
11. Burnstock G., Williams M. P2 purinergic receptors: modulation of cell function and therapeutic potential. J Pharmacol Exp Ther 2000, 295(3):862-869.
12. Brook M.M., Fineman J.R., Bolinger A.M., Wong A.F., Heymann M.A., Soifer S.J. Use of ATP-MgCl2 in the evaluation and treatment of children with pulmonary hypertension secondary to congenital heart defects. Circulation 1994, 90(3):1287-1293.
13. Dawicki D.D., Chatterjee D., Wyche J., Rounds S. Extracellular ATP and adenosine cause apoptosis of pulmonary artery endothelial cells. Am J Physiol 1997, 273(2 Pt 1):L485-L494.
14. McAuslan B.R., Reilly W.G., Hannan G.N., Gole G.A. Angiogenic factors and their assay: activity of formyl methionyl leucyl phenylalanine, adenosine diphosphate, heparin, copper, and bovine endothelium stimulating factor. Microvasc Res 1983, 26(3):323-338.
15. Fuentes E., Palomo I. Relationship between Platelet PPARs, cAMP Levels, and P-Selectin Expression: Antiplatelet Activity of Natural Products. Evid Based Complement Alternat Med 2013, 2013:861786.
16. Gregg D., Goldschmidt-Clermont P.J. Cardiology patient page Platelets and cardiovascular disease. Circulation 2003, 108(13):e88-e90.
17. Jackson S.P., Nesbitt W.S., Westein E. Dynamics of platelet thrombus formation. J Thromb Haemost 2009, 7(Suppl. 1):17-20.
18. Offermanns S. Activation of platelet function through G protein-coupled receptors. Circ Res 2006, 99(12):1293-1304.
19. Frenette P.S., Johnson R.C., Hynes R.O., Wagner D.D. Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc Natl Acad Sci U S A 1995, 92(16):7450-7454.
20. Idzko M., Ferrari D., Riegel A.K., Eltzschig H.K. Extracellular nucleotide and nucleoside signaling in vascular and blood disease. Blood 2014, 124(7):1029-1037.
21. Anwar J., Spanevello R.M., Pimentel V.C., Gutierres J., Thome G., Cardoso A., et al. Caffeic acid treatment alters the extracellular adenine nucleotide hydrolysis in platelets and lymphocytes of adult rats. Food Chem Toxicol 2013, 56:459-466.
22. Gutierres J.M., Carvalho F.B., Schetinger M.R., Rodrigues M.V., Vieira J.M., Maldonado P., et al. Alterations in the extracellular catabolism of nucleotides and platelet aggregation induced by high-fat diet in rats: effects of alpha-tocopherol. J Physiol Biochem 2014, 70(2):487-496.
23. Clemetson K.J. Platelets and primary haemostasis. Thromb Res 2012, 129(3):220-224.
24. Freedman J.E. Molecular regulation of platelet-dependent thrombosis. Circulation 2005, 112(17):2725-2734.
25. George J.N. Platelets. Lancet 2000, 355(9214):1531-1539.
26. Davi G., Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007, 357(24):2482-2494.
27. Nesbitt W.S., Westein E., Tovar-Lopez F.J., Tolouei E., Mitchell A., Fu J., et al. A shear gradient-dependent platelet aggregation mechanism drives thrombus formation. Nat Med 2009, 15(6):665-673.
28. Ruggeri Z.M. Platelets in atherothrombosis. Nat Med 2002, 8(11):1227-1234.
29. Jackson S.P. The growing complexity of platelet aggregation. Blood 2007, 109(12):5087-5095.
30. Santos M., Aranda E., Vallés J., Palomo I. Hemostasia Primaria. Hematología: Fisiopatología y Diagnóstico 2005, 459-492. Editorial Universidad de Talca. I. Palomo, J. Pereira, J. Palma (Eds.).
31. Li Z., Delaney M.K., O'Brien K.A., Du X. Signaling during platelet adhesion and activation. Arterioscler Thromb Vasc Biol 2010, 30(12):2341-2349.
32. Li Z., Zhang G., Le Breton G.C., Gao X., Malik A.B., Du X. Two waves of platelet secretion induced by thromboxane A2 receptor and a critical role for phosphoinositide 3-kinases. J Biol Chem 2003, 278(33):30725-30731.
33. Soslau G., Youngprapakorn D. A possible dual physiological role of extracellular ATP in the modulation of platelet aggregation. Biochim Biophys Acta 1997, 1355(2):131-140.
34. Gachet C. ADP receptors of platelets and their inhibition. Thromb Haemost 2001, 86(1):222-232.
35. Bours M.J., Swennen E.L., Di Virgilio F., Cronstein B.N., Dagnelie P.C. Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 2006, 112(2):358-404.
36. Stafford N.P., Pink A.E., White A.E., Glenn J.R., Heptinstall S. Mechanisms involved in adenosine triphosphate-induced platelet aggregation in whole blood. Arterioscler Thromb Vasc Biol 2003, 23(10):1928-1933.
37. Fuentes E., Pereira J., Mezzano D., Alarcon M., Caballero J., Palomo I. Inhibition of platelet activation and thrombus formation by adenosine and inosine: studies on their relative contribution and molecular modeling. PLoS One 2014, 9(11). [e112741].
38. Dubyak G.R., el-Moatassim C. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol 1993, 265(3 Pt 1):C577-C606.
39. Holmsen H. Platelet metabolism and activation. Semin Hematol 1985, 22(3):219-240.
40. Oury C., Toth-Zsamboki E., Vermylen J., Hoylaerts M.F. The platelet ATP and ADP receptors. Curr Pharm Des 2006, 12(7):859-875.
41. Leon C., Hechler B., Freund M., Eckly A., Vial C., Ohlmann P., et al. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J Clin Invest 1999, 104(12):1731-1737.
42. Lenain N., Freund M., Leon C., Cazenave J.P., Gachet C. Inhibition of localized thrombosis in P2Y1-deficient mice and rodents treated with MRS2179, a P2Y1 receptor antagonist. J Thromb Haemost 2003, 1(6):1144-1149.
43. Murugappa S., Kunapuli S.P. The role of ADP receptors in platelet function. Front Biosci 2006, 11:1977-1986.
44. Jackson E.K., Ren J., Gillespie D.G., Dubey R.K. Extracellular 2',3'-cyclic adenosine 5'-monophosphate is a potent inhibitor of preglomerular vascular smooth muscle cell and mesangial cell growth. Hypertension 2010, 56(1):151-158.
45. Fuentes E., Pereira J., Alarcon M., Valenzuela C., Perez P., Astudillo L., et al. Protective Mechanisms of S. lycopersicum Aqueous Fraction (Nucleosides and Flavonoids) on Platelet Activation and Thrombus Formation: In Vitro, Ex Vivo and In Vivo Studies. Evid Based Complement Alternat Med 2013, 2013:609714.
46. Fuentes E., Badimon L., Caballero J., Padro T., Vilahur G., Alarcon M., et al. Protective mechanisms of adenosine 5'-monophosphate in platelet activation and thrombus formation. Thromb Haemost 2014, 111(3):491-507.
47. Hasko G., Linden J., Cronstein B., Pacher P. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 2008, 7(9):759-770.
48. Zhao Z., Makaritsis K., Francis C.E., Gavras H., Ravid K. A role for the A3 adenosine receptor in determining tissue levels of cAMP and blood pressure: studies in knock-out mice. Biochim Biophys Acta 2000, 1500(3):280-290.
49. Johnston-Cox H.A., Ravid K. Adenosine and blood platelets. Purinergic Signal 2011, 7(3):357-365.
50. Fredholm B.B., AP I.J., Jacobson K.A., Klotz K.N., Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 2001, 53(4):527-552.
51. Libersan D., Rousseau G., Merhi Y. Differential regulation of P-selectin expression by protein kinase A and protein kinase G in thrombin-stimulated human platelets. Thromb Haemost 2003, 89(2):310-317.
52. Schwarz U.R., Kobsar A.L., Koksch M., Walter U., Eigenthaler M. Inhibition of agonist-induced p42 and p38 mitogen-activated protein kinase phosphorylation and CD40 ligand/P-selectin expression by cyclic nucleotide-regulated pathways in human platelets. Biochem Pharmacol 2000, 60(9):1399-1407.
53. Cristalli G., Costanzi S., Lambertucci C., Lupidi G., Vittori S., Volpini R., et al. Adenosine deaminase: functional implications and different classes of inhibitors. Med Res Rev 2001, 21(2):105-128.
54. Hasko G., Kuhel D.G., Nemeth Z.H., Mabley J.G., Stachlewitz R.F., Virag L., et al. Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock. J Immunol 2000, 164(2):1013-1019.
55. Altman R., Rouvier J., Weisenberger H. Identification of platelet inhibitor present in the melon (Cucurbitacea cucumis melo). Thromb Haemost 1985, 53(3):312-313.
56. Dutta-Roy A.K., Crosbie L., Gordon M.J. Effects of tomato extract on human platelet aggregation in vitro. Platelets 2001, 12(4):218-227.
57. Hasko G., Sitkovsky M.V., Szabo C. Immunomodulatory and neuroprotective effects of inosine. Trends Pharmacol Sci 2004, 25(3):152-157.
58. Hsiao G., Lin K.H., Chang Y., Chen T.L., Tzu N.H., Chou D.S., et al. Protective mechanisms of inosine in platelet activation and cerebral ischemic damage. Arterioscler Thromb Vasc Biol 2005, 25(9):1998-2004.
59. Homolya L., Steinberg T.H., Boucher R.C. Cell to cell communication in response to mechanical stress via bilateral release of ATP and UTP in polarized epithelia. J Cell Biol 2000, 150(6):1349-1360.
60. Kim M.S., Lee J., Ha J., Kim S.S., Kong Y., Cho Y.H., et al. ATP stimulates glucose transport through activation of P2 purinergic receptors in C(2)C(12) skeletal muscle cells. Arch Biochem Biophys 2002, 401(2):205-214.
61. Save S., Persson K. Extracellular ATP and P2Y receptor activation induce a proinflammatory host response in the human urinary tract. Infect Immun 2010, 78(8):3609-3615.
62. Fader C.M., Aguilera M.O., Colombo M.I. ATP is released from autophagic vesicles to the extracellular space in a VAMP7-dependent manner. Autophagy 2012, 8(12):1741-1756.
63. Luna C., Li G., Qiu J., Challa P., Epstein D.L., Gonzalez P. Extracellular release of ATP mediated by cyclic mechanical stress leads to mobilization of AA in trabecular meshwork cells. Invest Ophthalmol Vis Sci 2009, 50(12):5805-5810.
64. Arcuino G., Lin J.H., Takano T., Liu C., Jiang L., Gao Q., et al. Intercellular calcium signaling mediated by point-source burst release of ATP. Proc Natl Acad Sci U S A 2002, 99(15):9840-9845.
65. Eltzschig H.K., Macmanus C.F., Colgan S.P. Neutrophils as sources of extracellular nucleotides: functional consequences at the vascular interface. Trends Cardiovasc Med 2008, 18(3):103-107.
66. Sakaki H., Tsukimoto M., Harada H., Moriyama Y., Kojima S. Autocrine regulation of macrophage activation via exocytosis of ATP and activation of P2Y11 receptor. PLoS One 2013, 8(4). [e59778].
67. Novak I. ATP as a signaling molecule: the exocrine focus. News Physiol Sci 2003, 18:12-17.
68. Schenk U., Westendorf A.M., Radaelli E., Casati A., Ferro M., Fumagalli M., et al. Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels. Sci Signal 2008, 1(39). [ra6.].
69. Kuehnel M.P., Reiss M., Anand P.K., Treede I., Holzer D., Hoffmann E., et al. Sphingosine-1-phosphate receptors stimulate macrophage plasma-membrane actin assembly via ADP release, ATP synthesis and P2X7R activation. J Cell Sci 2009, 122(Pt 4):505-512.
70. Okada S.F., Ribeiro C.M., Sesma J.I., Seminario-Vidal L., Abdullah L.H., van Heusden C., et al. Inflammation promotes airway epithelial ATP release via calcium-dependent vesicular pathways. Am J Respir Cell Mol Biol 2013, 49(5):814-820.
71. Cotrina M.L., Lin J.H., Lopez-Garcia J.C., Naus C.C., Nedergaard M. ATP-mediated glia signaling. J Neurosci 2000, 20(8):2835-2844.
72. Bodin P., Burnstock G. ATP-stimulated release of ATP by human endothelial cells. J Cardiovasc Pharmacol 1996, 27(6):872-875.
73. Pearson J.D., Gordon J.L. Vascular endothelial and smooth muscle cells in culture selectively release adenine nucleotides. Nature 1979, 281(5730):384-386.
74. Faigle M., Seessle J., Zug S., El Kasmi K.C., Eltzschig H.K. ATP release from vascular endothelia occurs across Cx43 hemichannels and is attenuated during hypoxia. PLoS One 2008, 3(7). [e2801].
75. Yamamoto K., Furuya K., Nakamura M., Kobatake E., Sokabe M., Ando J. Visualization of flow-induced ATP release and triggering of Ca2+ waves at caveolae in vascular endothelial cells. J Cell Sci 2011, 124(Pt 20):3477-3483.
76. Yamamoto K., Sokabe T., Matsumoto T., Yoshimura K., Shibata M., Ohura N., et al. Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice. Nat Med 2006, 12(1):133-137.
77. Lohman A., Isakson B. Pannexin 1-dependent ATP release from venous endothelium promotes acute vascular inflammation. FASEB J 2014, 28(1 Supplement).
78. Burgers J.A., Schweizer R.C., Koenderman L., Bruijnzeel P.L., Akkerman J.W. Human platelets secrete chemotactic activity for eosinophils. Blood 1993, 81(1):49-55.
79. Marcus A.J., Broekman M.J., Drosopoulos J.H., Islam N., Pinsky D.J., Sesti C., et al. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases. J Pharmacol Exp Ther 2003, 305(1):9-16.
80. Hiasa M., Togawa N., Miyaji T., Omote H., Yamamoto A., Moriyama Y. Essential role of vesicular nucleotide transporter in vesicular storage and release of nucleotides in platelets. Physiol Rep 2014, 2(6).
81. Taylor K.A., Wright J.R., Vial C., Evans R.J., Mahaut-Smith M.P. Amplification of human platelet activation by surface pannexin-1 channels. J Thromb Haemost 2014, 12(6):987-998.
82. Wan J., Ristenpart W.D., Stone H.A. Dynamics of shear-induced ATP release from red blood cells. Proc Natl Acad Sci U S A 2008, 105(43):16432-16437.
83. Kobayashi S., Hamazaki T., Sawazaki S., Nakamura H. Reduction in the ADP release from shear-stressed red blood cells by fish oil administration. Thromb Res 1992, 65(3):353-364.
84. Umapathy N.S., Fan Z., Zemskov E.A., Alieva I.B., Black S.M., Verin A.D. Molecular mechanisms involved in adenosine-induced endothelial cell barrier enhancement. Vascul Pharmacol 2010, 52(5-6):199-206.
85. Matthews J.B., Tally K.J., Smith J.A., Zeind A.J., Hrnjez B.J. Activation of Cl secretion during chemical hypoxia by endogenous release of adenosine in intestinal epithelial monolayers. J Clin Invest 1995, 96(1):117-125.
86. Mun E.C., Tally K.J., Matthews J.B. Characterization and regulation of adenosine transport in T84 intestinal epithelial cells. Am J Physiol 1998, 274(2 Pt 1):G261-G269.
87. Brundege J.M., Dunwiddie T.V. Metabolic regulation of endogenous adenosine release from single neurons. Neuroreport 1998, 9(13):3007-3011.
88. Brambilla D., Chapman D., Greene R. Adenosine mediation of presynaptic feedback inhibition of glutamate release. Neuron 2005, 46(2):275-283.
89. Lovatt D., Xu Q., Liu W., Takano T., Smith N.A., Schnermann J., et al. Neuronal adenosine release, and not astrocytic ATP release, mediates feedback inhibition of excitatory activity. Proc Natl Acad Sci U S A 2012, 109(16):6265-6270.
90. Dosne A.M., Legrand C., Bauvois B., Bodevin E., Caen J.P. Comparative degradation of adenylnucleotides by cultured endothelial cells and fibroblasts. Biochem Biophys Res Commun 1978, 85(1):183-189.
91. Dieterle Y., Ody C., Ehrensberger A., Stalder H., Junod A.F. Metabolism and uptake of adenosine triphosphate and adenosine by porcine aortic and pulmonary endothelial cells and fibroblasts in culture. Circ Res 1978, 42(6):869-876.
92. Pearson J.D., Carleton J.S., Gordon J.L. Metabolism of adenine nucleotides by ectoenzymes of vascular endothelial and smooth-muscle cells in culture. Biochem J 1980, 190(2):421-429.
93. Marcus A.J., Broekman M.J., Drosopoulos J.H., Islam N., Alyonycheva T.N., Safier L.B., et al. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 1997, 99(6):1351-1360.
94. Zimmermann H. Nucleotides and cd39: principal modulatory players in hemostasis and thrombosis. Nat Med 1999, 5(9):987-988.
95. Marcus A.J., Broekman M.J., Drosopoulos J.H., Islam N., Pinsky D.J., Sesti C., et al. Heterologous cell-cell interactions: thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase-1). J Thromb Haemost 2003, 1(12):2497-2509.
96. Strohmeier G.R., Lencer W.I., Patapoff T.W., Thompson L.F., Carlson S.L., Moe S.J., et al. Surface expression, polarization, and functional significance of CD73 in human intestinal epithelia. J Clin Invest 1997, 99(11):2588-2601.
97. Salmi M., Jalkanen S. Cell-surface enzymes in control of leukocyte trafficking. Nat Rev Immunol 2005, 5(10):760-771.
98. Colgan S.P., Eltzschig H.K., Eckle T., Thompson L.F. Physiological roles for ecto-5'-nucleotidase (CD73). Purinergic Signal 2006, 2(2):351-360.
99. Yegutkin G.G. Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade. Biochim Biophys Acta 2008, 1783(5):673-694.
100. Hasko G., Cronstein B.N. Adenosine: an endogenous regulator of innate immunity. Trends Immunol 2004, 25(1):33-39.
101. Robillard K.R., Bone D.B., Hammond J.R. Hypoxanthine uptake and release by equilibrative nucleoside transporter 2 (ENT2) of rat microvascular endothelial cells. Microvasc Res 2008, 75(3):351-357.
102. Coade S.B., Pearson J.D. Metabolism of adenine nucleotides in human blood. Circ Res 1989, 65(3):531-537.
103. Yegutkin G.G., Wieringa B., Robson S.C., Jalkanen S. Metabolism of circulating ADP in the bloodstream is mediated via integrated actions of soluble adenylate kinase-1 and NTPDase1/CD39 activities. FASEB J 2012, 26(9):3875-3883.
104. Jiang Z.G., Wu Y., Csizmadia E., Feldbrugge L., Enjyoji K., Tigges J., et al. Characterization of circulating microparticle-associated CD39 family ecto-nucleotidases in human plasma. Purinergic Signal 2014, 10(4):611-618.
105. Reynolds A., Huttinger Z.M., Aurand W.L., Huttinger R.M., Stanfill K., Wheeler D.G., et al. Abstract 19: CD39 Expression on Circulating Blood Components Prolongs the Time to Ferric Chloride-Induced Carotid Artery Thrombosis in Mice. Arterioscler Thromb Vasc Biol 2014, 34(Suppl. 1). [A19.].
106. Rissiek A., Baumann I., Cuapio A., Mautner A., Kolster M., Arck P.C., et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun 2015, 58:12-20.
107. Kanthi Y.M., Sutton N.R., Pinsky D.J. CD39: Interface between vascular thrombosis and inflammation. Curr Atheroscler Rep 2014, 16(7):425.
108. Pulte D., Olson K.E., Broekman M.J., Islam N., Ballard H.S., Furman R.R., et al. CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia. J Transl Med 2007, 5:23.
109. Birk A.V., Broekman M.J., Gladek E.M., Robertson H.D., Drosopoulos J.H., Marcus A.J., et al. Role of extracellular ATP metabolism in regulation of platelet reactivity. J Lab Clin Med 2002, 140(3):166-175.
110. El-Omar M.M., Islam N., Broekman M.J., Drosopoulos J.H., Roa D.C., Lorin J.D., et al. The ratio of ADP- to ATP-ectonucleotidase activity is reduced in patients with coronary artery disease. Thromb Res 2005, 116(3):199-206.
111. Haller C.A., Cui W., Wen J., Robson S.C., Chaikof E.L. Reconstitution of CD39 in liposomes amplifies nucleoside triphosphate diphosphohydrolase activity and restores thromboregulatory properties. J Vasc Surg 2006, 43(4):816-823.
112. Huttinger Z.M., Milks M.W., Nickoli M.S., Aurand W.L., Long L.C., Wheeler D.G., et al. Ectonucleotide triphosphate diphosphohydrolase-1 (CD39) mediates resistance to occlusive arterial thrombus formation after vascular injury in mice. Am J Pathol 2012, 181(1):322-333.
113. Wheeler D.G., Joseph M.E., Mahamud S.D., Aurand W.L., Mohler P.J., Pompili V.J., et al. Transgenic swine: expression of human CD39 protects against myocardial injury. J Mol Cell Cardiol 2012, 52(5):958-961.
114. Cai M., Huttinger Z.M., He H., Zhang W., Li F., Goodman L.A., et al. Transgenic over expression of ectonucleotide triphosphate diphosphohydrolase-1 protects against murine myocardial ischemic injury. J Mol Cell Cardiol 2011, 51(6):927-935.
115. Drosopoulos J.H., Broekman M.J., Islam N., Maliszewski C.R., Gayle R.B., Marcus A.J. Site-directed mutagenesis of human endothelial cell ecto-ADPase/soluble CD39: requirement of glutamate 174 and serine 218 for enzyme activity and inhibition of platelet recruitment. Biochemistry 2000, 39(23):6936-6943.
116. Marcus A.J., Broekman M.J., Drosopoulos J.H., Olson K.E., Islam N., Pinsky D.J., et al. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection. Semin Thromb Hemost 2005, 31(2):234-246.
117. Buergler J.M., Maliszewski C.R., Broekman M.J., Kaluza G.L., Schulz D.G., Marcus A.J., et al. Effects of SolCD39, a novel inhibitor of Platelet Aggregation, on Platelet Deposition and Aggregation after PTCA in a Porcine Model. J Thromb Thrombolysis 2005, 19(2):115-122.
118. Imai M., Kaczmarek E., Koziak K., Sevigny J., Goepfert C., Guckelberger O., et al. Suppression of ATP diphosphohydrolase/CD39 in human vascular endothelial cells. Biochemistry 1999, 38(41):13473-13479.
119. Kishi Y., Ohta S., Kasuya N., Sakita S.Y., Ashikaga T., Isobe M. Perindopril augments ecto-ATP diphosphohydrolase activity and enhances endothelial anti-platelet function in human umbilical vein endothelial cells. J Hypertens 2003, 21(7):1347-1353.
120. Kaneider N.C., Egger P., Dunzendorfer S., Noris P., Balduini C.L., Gritti D., et al. Reversal of thrombin-induced deactivation of CD39/ATPDase in endothelial cells by HMG-CoA reductase inhibition: effects on Rho-GTPase and adenosine nucleotide metabolism. Arterioscler Thromb Vasc Biol 2002, 22(6):894-900.
121. Eltzschig H.K., Thompson L.F., Karhausen J., Cotta R.J., Ibla J.C., Robson S.C., et al. Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood 2004, 104(13):3986-3992.
122. Eltzschig H.K., Kohler D., Eckle T., Kong T., Robson S.C., Colgan S.P. Central role of Sp1-regulated CD39 in hypoxia/ischemia protection. Blood 2009, 113(1):224-232.
123. Liao H., Hyman M.C., Baek A.E., Fukase K., Pinsky D.J. cAMP/CREB-mediated transcriptional regulation of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) expression. J Biol Chem 2010, 285(19):14791-14805.
124. Baek A.E., Kanthi Y., Sutton N.R., Liao H., Pinsky D.J. Regulation of ecto-apyrase CD39 (ENTPD1) expression by phosphodiesterase III (PDE3). FASEB J 2013, 27(11):4419-4428.